Machine Learning in Hypertrophic Cardiomyopathy: Nonlinear Model From Clinical and CMR Features

Kankan Zhao1, Yanjie Zhu2, Xiuyu Chen3

  • 1Paul C. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, SZ University Town, Shenzhen, China; Shenzhen College of Advanced Technology, University of Chinese Academy of Sciences, Beijing, China.

PubMed

Insights

Machine learning accurately predicts major adverse cardiovascular events (MACEs) in hypertrophic cardiomyopathy (HCM) patients using cardiac magnetic resonance (CMR) imaging and clinical data. This approach surpasses traditional risk models, offering improved risk stratification for HCM management.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Machine Learning

Background:

  • Hypertrophic cardiomyopathy (HCM) poses a significant clinical burden, with 10-15% of patients experiencing major adverse cardiovascular events (MACEs) annually.
  • Existing risk stratification models for HCM have limited accuracy in predicting sudden cardiac death (SCD) and do not incorporate cardiac magnetic resonance (CMR) parameters.

Purpose of the Study:

  • To develop and validate a machine learning (ML) framework for predicting MACEs in HCM patients.
  • Integrate CMR imaging features and clinical characteristics into an ML model for enhanced risk prediction.

Main Methods:

  • Utilized data from 758 HCM patients across four medical centers (2010-2017).
  • Developed an ML model using light gradient-boosting machine on an internal cohort (533 patients) and validated it externally on 225 patients.
  • Incorporated 14 CMR imaging features (including strain and late gadolinium enhancement [LGE]) and 23 clinical variables.

Main Results:

  • The ML model achieved areas under the curve (AUCs) of 0.830 (internal) and 0.812 (external), outperforming the classic HCM Risk-SCD model by 22.7% (P < 0.001).
  • MACEs occurred in 25% of patients over a median follow-up of 109 months.
  • Nonlinear correlations were found between LGE extent, global radial strain (GRS), global circumferential strain (GCS), and MACEs.

Conclusions:

  • ML-based risk stratification integrating CMR and clinical data provides accurate MACE prediction in HCM, exceeding traditional models.
  • Identified nonlinear relationships between CMR features (LGE, left ventricular pressure gradient) and MACEs, offering valuable clinical insights for HCM assessment and management.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
837
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762